Navigation Links
BrainCells Inc. Expands Series B Financing to $50 Million
Date:4/17/2008

August 2006 and used its proprietary platform technology to identify the compound's neurogenic profile, which is comparable to antidepressants on the market today, but that has shown in pre-clinical studies to not affect serotonin levels, which could avoid the negative side effects associated with existing therapies.

"With an eye on innovative companies providing solutions for clinically unmet needs, we find BCI's ability to leverage its neurogenic screening technology to identify and develop new treatments for CNS disorders to be extremely promising," said Chuck Newhall, general partner and co-founder of NEA. "I look forward to joining the BCI board and seeing the company through a transformational year with several anticipated clinical milestones."

About BrainCells Inc.

BrainCells Inc. (BCI) is a San Diego-based drug discovery and development company that is applying its proprietary neurogenesis platform technology to identify and reposition compounds for the treatment of central nervous system (CNS) diseases. Neurogenesis is the process by which endogenous stem cells in the adult human brain produce new brain tissue, including neurons. With its predictive screening platform, BCI can direct the selection and development of neurogenic compounds, increasing the opportunity for successful clinical trials in a variety of CNS indications. For more information, visit http://www.braincellsinc.com.

Media Contact:

Kim Richards

Porter Novelli Life Sciences

619-849-5377

krichards@pnlifesciences.com


'/>"/>
SOURCE BrainCells Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
2. ATS Medical Expands Open Pivot Heart Valve Offerings
3. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
4. BioLife Solutions Expands Scientific Advisory Board
5. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
6. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
7. Pharsight Expands Strategic Consulting Services Team
8. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
9. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
10. AQUISS Expands Into Significant New Territory
11. NanoBio Expands Drug Development Team for Its Anti-Infective Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...e Webcast -, MONTVALE, N.J., May 12 /PRNewswire-F...YI ) announced today that Noah Berkowitz, M.D., Ph...sta will present at the upcoming Rodman,& Renshaw ... May 19, 2008,at 12:10 p.m. CEST (6:10 a.m. EDT). ... Le Meridien Beach Plaza Hotel in Monte Carlo., D...
(Date:5/12/2008)...nformed Medical Communications,(IMC), a leading pr...pharmaceutical industry, today announced the appoi...eting. In this role, Stoogenke will,develop and im...logue and,IMC with the objective to maintain and g...Logo: http://www.newscom.com/cgi-bin/prnh/2008051...
(Date:5/12/2008)... the community and its biotech ...swire-FirstCall/ -- Eli Lilly and Company,(NYSE: ...e of its $1 billion,effort to further strengthen t...t capabilities., At a ceremony at its Indianapoli...ation by Indianapolis Mayor Gregory Ballard, dedic...
(Date:5/12/2008)...-FirstCall/ -- Nektar,Therapeutics (Nasdaq: NKTR ...n technology is used in the novel therapeutic, Hem...is-stimulating agent that is under,development by ...and,Affymax. Data were presented for Hematide(TM) ...Sweden, which showed that Hematide(TM) administere...
Breaking Biology Technology:Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 2Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 3Informed Medical Communications Hires New Vice President of Marketing 2Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex 2Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex 3Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress 2Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress 3
...iana Davis, Aiguo Zhang, Jim Torrence, and Emily D...el Drive, Hercules, CA 94547 USA , , ...assays are bead-based quantitative multiplex immun... in these assays are quantitated using a , ...ysis is performed to derive , an equation...
...hloe Etienne, Allan Gandy, Diana Davis, and Aiguo ...obel Drive, Hercules, CA 94547 USA , , ...pension array system is an integrated system consi...kits. The system employs bead-based Luminex , ...0 targets in a single microplate , well. ...
...ian Gao, Kris Simonyi, and Claudia Suen, Bio-Rad L...ules, CA 94547 USA , , Introduc...l technique for detecting phosphorylated , ...ssue sample lysates. In , recent years, n...re approach , have become available for d...
..., AquaPure RNA Isolation Kit , ...ple and RNA expression levels , , ...ndling , Samples may be fresh or frozen... quickly as possible; store at 18C for not more t... at -70 to -80C. , Cell Lysis , ...
Other Biology Technology:Selection of Standards for Bio-Plex Cytokine Assays, Rev A 2Selection of Standards for Bio-Plex Cytokine Assays, Rev A 3Selection of Standards for Bio-Plex Cytokine Assays, Rev A 4Selection of Standards for Bio-Plex Cytokine Assays, Rev A 5Selection of Standards for Bio-Plex Cytokine Assays, Rev A 6Selection of Standards for Bio-Plex Cytokine Assays, Rev A 7Selection of Standards for Bio-Plex Cytokine Assays, Rev A 8Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 2Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 3Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 4Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 5Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 2Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 3Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 4Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 5Total RNA Isolation: 100 l Viral Sample From Cultured-Cell Supernatant Containing Virus 2
(Date:5/12/2008)..., 2008 There exists much ethical controversy brou...the relationship to religion. In a new essay in Th... takes an approach to medical ethics that draws up...w how acting to change the world is indicative of ...r how the natural world functions and why humans b...
(Date:5/12/2008)...evGenUK) is being launched at the John Innes Centr...ants grow. , This knowledge can be used to impr...ions or to grow more sustainably with reduced nitr...million from the Biotechnology and Biological Scie...on the JICs expertise in TILLING, a technique to d...
(Date:5/12/2008)...on years of evolution has taken two unlikely dista...rent physical paths from a common ancestor. But Un...tor protein, myosin 2, remains structurally identi...s that the tiny motor protein is much more importa...even hold a key to understanding potentially fatal...
(Date:5/12/2008)...ay released a 20-year study showing that environme...ve effect on reducing overall contaminant levels i...points to continuing concerns with elevated levels...an and industrial areas of the coasts. , Its... and industrial chemicals, such as PCBs, show sign...
Breaking Biology News(10 mins):Religion and the narrative of biological science 2Ancient protein offers clues to killer condition 2NOAA reports coastal waters show decline in contaminants 2NOAA reports coastal waters show decline in contaminants 3DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 1DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 2DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 3DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 4DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 5DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 6DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 7DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 8DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 9DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 10DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 11DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 12DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 13DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 14DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 15DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 16DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 17DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 18Survey 3A Employers Have High Confidence They Can Control Health Care Costs With Proper Tools 17389 1Survey 3A Employers Have High Confidence They Can Control Health Care Costs With Proper Tools 17389 2Survey 3A Employers Have High Confidence They Can Control Health Care Costs With Proper Tools 17389 3JIC Invests in Three New Alternative Energy Projects 4751 1JIC Invests in Three New Alternative Energy Projects 4751 2JIC Invests in Three New Alternative Energy Projects 4751 3JIC Invests in Three New Alternative Energy Projects 4751 4JIC Invests in Three New Alternative Energy Projects 4751 5Fufeng Announces 2007 Annual Results 4750 1Fufeng Announces 2007 Annual Results 4750 2Fufeng Announces 2007 Annual Results 4750 3
...ed Hitchcock,s "The Birds" made many of us uneasy ...blic health officials around the world are beginni...birds, especially in Alaska, following recent outb...st week, in Siberia. , Alaska is at the intersecti...ratory birds and scientists say that could provide...
... University will lead an interdisciplinary team of...elp improve one of the most important food crops i...oundation selected the BioCassava Plus project as ...lenges in Global Health" program grants. Created t... is to fund innovative solutions to global health ...
...e studies of captive breeding strategies conducted...d sometimes troublesome breeding programs that pre...ions of endangered species. , Worldwide, zoos spen...animals thousands of miles in order to breed them ...have questioned the need for such programs, which ...
... have discovered that a group of important immune ...atic British superspy James Bond: the cells receiv...st potent attacks on enemies. , This licensing pro...cells will erroneously direct their firepower at t... Washington University School of Medicine in St. L...
Other Biology News:On a wing and a prayer - Alaska researchers seek clues to bird flu 2On a wing and a prayer - Alaska researchers seek clues to bird flu 3Research team receives $7.5 million to study cassava 2Costly breeding programs for endangered species pay off 2Costly breeding programs for endangered species pay off 3'License to kill' enables powerful immune attack cells in mice 2'License to kill' enables powerful immune attack cells in mice 3
Tracker Datamatrix RS-1* reads 96 2D Bar-coded tubes within 20 seconds.
Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19
Request Info
Human TIMP-1 ELISpot Development Kit from R&D Systems
Biology Products: